Pressures to get products to the market are ever increasing so working in a well- controlled, compliant manner during all phases of development is essential if market approval of a product is to be achieved. Although there is some guidance available, often those involved are unsure of how much “GMP” is required and when it is required. Once Investigational Medicinal Product (IMP) manufacture has been initiated, it becomes a little easier, however there are still some flexibilities allowed depending on the phase of the clinical trials involved. There is therefore a need for some practical GMP guidance for these important stages of the product lifecycle and sharing of experiences.
An introductory course on applicable GMPs to be applied during Pharmaceutical Product Development including IMP manufacture for Pharmaceutical professionals working in the industry, NHS or academic institutions, wanting to learn about some of the differences and challenges associated with the development process and how to ensure compliance with relevant GMPs.
An introductory course on applicable GMPs to be applied during Pharmaceutical Product Development including IMP manufacture for Pharmaceutical professionals working in the industry, NHS or academic institutions, wanting to learn about some of the differences and challenges associated with the development process and how to ensure compliance with relevant GMPs.
